These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29081164)

  • 1. [Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease].
    Zeng QL; Wang XM; Li SN; Xiong B; Jian M; Huang G; Wu YQ; Wang XH; Li J; Wen FQ; Zhou H
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(40):3166-3170. PubMed ID: 29081164
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood eosinophils: a biomarker of response to glucocorticoids and increased readmissions in severe hospitalized exacerbations of COPD].
    Xue J; Cui YN; Chen P; Cai S; Chen L; Dai ZS; Chen Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):426-431. PubMed ID: 31189228
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated Peripheral Blood Eosinophils during Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and clinical significance.
    Al Sibani M; Al Alawi A; Al Aghbari J
    Sultan Qaboos Univ Med J; 2022 Aug; 22(3):339-342. PubMed ID: 36072062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and three-year prognosis of AECOPD patients with different levels of blood eosinophils.
    Ruiying W; Zhaoyun ; Jianying X
    Heart Lung; 2022; 56():29-39. PubMed ID: 35687923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD.
    Prins HJ; Duijkers R; Lutter R; Daniels JM; van der Valk P; Schoorl M; Kerstjens HA; van der Werf TS; Boersma WG
    Respir Med; 2017 Oct; 131():118-124. PubMed ID: 28947018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
    Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
    BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?
    Saltürk C; Karakurt Z; Adiguzel N; Kargin F; Sari R; Celik ME; Takir HB; Tuncay E; Sogukpinar O; Ciftaslan N; Mocin O; Gungor G; Oztas S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1837-46. PubMed ID: 26392758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.
    Zhang Y; Liang LR; Zhang S; Lu Y; Chen YY; Shi HZ; Lin YX
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1123-1134. PubMed ID: 32547000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Differences between Eosinophilic and Noneosinophilic Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study.
    Dai G; Ran Y; Wang J; Chen X; Peng J; Li X; Deng H; Xiao M; Zhu T
    Mediators Inflamm; 2020; 2020():1059079. PubMed ID: 33273887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic bronchiectasis increases length and cost of hospitalization: a retrospective analysis in a hospital of southern China from 2012 to 2020.
    Lei C; Zeng Z; Chen F; Guo Y; Liu Y
    BMC Pulm Med; 2024 Feb; 24(1):98. PubMed ID: 38408986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Eosinophils and Clinical Outcome of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
    You Y; Shi GC
    Respiration; 2021; 100(3):228-237. PubMed ID: 33373986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of peripheral eosinophilia in acute exacerbation of chronic obstructive pulmonary disease.
    Wu CW; Lan CC; Hsieh PC; Tzeng IS; Wu YK
    World J Clin Cases; 2020 Jul; 8(13):2727-2737. PubMed ID: 32742983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes.
    Aksoy E; Karakurt Z; Gungor S; Ocakli B; Ozmen İ; Yildirim E; Tuncay E; Agca MC; Ciftaslan Goksenoglu N; Adigüzel N
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2721-2730. PubMed ID: 30233162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
    Kiani A; Rahimi F; Afaghi S; Paat M; Varharam M; Dizaji MK; Dastoorpoor M; Abedini A
    Can Respir J; 2023; 2023():8678702. PubMed ID: 37153722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Influenza PCR Positivity in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Chen CYJ; Yew MS; Abisheganaden JA; Xu H
    Int J Chron Obstruct Pulmon Dis; 2022; 17():25-32. PubMed ID: 35023911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical investigation on the related factors for the application of systemic glucocorticoids in patients with acute exacerbation of chronic obstructive pulmonary disease with carbon dioxide retention].
    Jiao W; Zhang W; Zhang C; Liu Z; Gan Y; Peng Z; Yan G; Deng X; Xue Q; Wu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1061-1066. PubMed ID: 33081891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.
    Sivapalan P; Moberg M; Eklöf J; Janner J; Vestbo J; Laub RR; Browatzki A; Armbruster K; Wilcke JT; Seersholm N; Weinreich UM; Titlestad IL; Andreassen HF; Ulrik CS; Bødtger U; Nielsen TL; Hansen EF; Jensen JUS
    BMC Pulm Med; 2017 Aug; 17(1):114. PubMed ID: 28810909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation?
    Çoban Ağca M; Aksoy E; Duman D; Özmen İ; Yıldırım E; Güngör S; Durmuş N; Aka Aktürk Ü; Saltürk C; Tepetam FM; Karakurt Z
    Tuberk Toraks; 2017 Dec; 65(4):282-290. PubMed ID: 29631526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Eosinophils and Clinical Outcomes in Inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study.
    Pu J; Yi Q; Luo Y; Wei H; Ge H; Liu H; Li X; Zhang J; Pan P; Zhou H; Zhou C; Yi M; Cheng L; Liu L; Zhang J; Peng L; Aili A; Liu Y; Zhou H;
    Int J Chron Obstruct Pulmon Dis; 2023; 18():169-179. PubMed ID: 36879668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.